A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae.
Saved in:
| Title: | A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae. |
|---|---|
| Authors: | Uehara T; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Zulli AL; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Miller B; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Avery LM; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Boyd SA; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Chatwin CL; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Chu GH; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Drager AS; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Edwards M; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Emeigh Hart SG; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Myers CL; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Rongala G; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Stevenson A; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Uehara K; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Yi F; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Wang B; BioDuro-Sundia, Beijing, China., Liu Z; BioDuro-Sundia, Beijing, China., Wang M; BioDuro-Sundia, Beijing, China., Zhao Z; BioDuro-Sundia, Beijing, China., Zhou X; BioDuro-Sundia, Beijing, China., Zhao H; BioDuro-Sundia, Beijing, China., Stratton CM; Department of Biochemistry & Molecular Biology, University of South Alabama, Mobile, AL, USA., Bala S; Department of Biochemistry & Molecular Biology, University of South Alabama, Mobile, AL, USA., Davies C; Department of Biochemistry & Molecular Biology, University of South Alabama, Mobile, AL, USA., Tkavc R; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Jerse AE; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Pevear DC; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Burns CJ; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Daigle DM; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA., Condon SM; Venatorx Pharmaceuticals, Inc., Malvern, PA, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2024 Dec 27. Date of Electronic Publication: 2024 Dec 27. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
